The Cooper Companies, Inc. (COO)
NASDAQ
Closed
Aug 24, 2026
Day's Range
75.6252 wk Range
58.89Overview - COO - The Cooper Companies, Inc.
Key Statistics
Valuation
Enterprise Value
17.45B
P/E (Trailing)
‪64.59‬
P/E (Forward)
‪15.25‬
PEG Ratio
‪-0.33‬
Price / Sales (TTM)
‪3.61‬
Price / Book
‪1.80‬
EV / EBITDA
‪19.69‬
Profitability
Gross Margin
‪67.99%‬
Profit Margin
‪5.57%‬
Operating Margin
‪-2.86%‬
Return on Assets
‪2.51%‬
Return on Equity
‪2.85%‬
Ownership
Shares Outstanding
194.91M
Float
193.67M
Short % of Shares Outstanding
‪4.88%‬
Held by Insiders
‪0.61%‬
Held by Institutions
‪109.22%‬
Price stats
Beta
‪0.82‬
50-Day Avg
‪71.84‬
200-Day Avg
‪73.35‬
Dividends
Payout Ratio
‪0.00%‬
Frequency
Semi-Annual
Analyst Consensus
16 analysts
Average price target
‪$ 81.50‬Shariah Compliance
Report Date: Feb 16, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - COO - The Cooper Companies, Inc.
Peers - COO - The Cooper Companies, Inc.
Peer Comparison
Compared with companies in Medical Instruments & Supplies listed on NASDAQ.
Profile Summary - COO - The Cooper Companies, Inc.
About
The Cooper Companies, Inc. is a global medical device company operating through two primary segments: CooperVision and CooperSurgical. CooperVision specializes in vision care, offering a comprehensive portfolio of contact lenses including spherical, multifocal, toric, and specialty lenses under brands such as…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
